Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

SIMPLE SUMMARY: Immunotherapy is the mainstay treatment for most solid tumours. However, its cardiotoxicity is not yet known and studied, and its uncertainty is even greater in elderly patients. For this reason, this ambispective study was conducted in 195 patients over 70 years of age who were trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Toribio-García, Irene, Olivares-Hernández, Alejandro, Miramontes-González, José Pablo, Domínguez, Luis Posado, Martín García, Ana, Eiros Bachiller, Rocío, Figuero-Pérez, Luis, Garijo Martínez, María, Roldán Ruiz, Jonnathan, Bellido Hernández, Lorena, Fonseca-Sánchez, Emilio, Luis Sánchez, Pedro, del Barco-Morillo, Edel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486692/
https://www.ncbi.nlm.nih.gov/pubmed/37686569
http://dx.doi.org/10.3390/cancers15174293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486692/
https://www.ncbi.nlm.nih.gov/pubmed/37686569
http://dx.doi.org/10.3390/cancers15174293

Ejemplares similares